Cervical most cancers, brought on by persistent human papillomavirus (HPV) an infection, is the main reason behind feminine most cancers deaths in South Africa. In 2014, the South African National Department of Health launched a free public sector school-based HPV vaccination programme, concentrating on grade Four ladies aged ≥9 years. However, personal sector faculty ladies obtain HPV vaccination by way of their healthcare suppliers at value. This research investigated HPV vaccination information, attitudes and practices of caregivers of ladies aged ≥9 years in grades 4-7 attending South African personal faculties.
A hyperlink to a web based survey was circulated to caregivers by way of an electronic mail despatched to high school principals of all personal faculties in 4 provinces enrolling ladies in grades 4-7. Following a poor post-reminder response, a paid Facebook survey-linked advert concentrating on South African Facebook customers aged ≥25 years nationally was run for Four days, and positioned on the South African Vaccination and Immunisation Centre’s Facebook web page for 20 days. Of 615 respondents, 413 supplied HPV vaccination information and 455 accomplished the information and attitudes assessments. Most (76.5%) caregivers had good information and 45.3% had optimistic attitudes.
Of their daughters, 19.4% had obtained ≥1 dose of HPV vaccine. Of caregivers of unvaccinated ladies, 44.3% and 41.1%, respectively have been prepared to vaccinate their daughters if vaccination was supplied free and at their faculty. Caregivers of unvaccinated ladies have been extra seemingly [odds ratio (OR): 3.8] to have been influenced by “different” influences (primarily on-line articles and anecdotal vaccine harm reviews). Of caregivers influenced by their healthcare suppliers, caregivers of unvaccinated ladies have been extra seemingly (OR: 0.2) to be influenced by different medical practitioners.
Caregivers of vaccinated ladies have been extra more likely to have good information (OR: 3.6) and optimistic attitudes (OR: 5.2). Having good information strongly predicted (OR: 2.8) optimistic attitudes. Having unfavourable attitudes strongly predicted (OR: 0.2) ladies being unvaccinated. Providing free school-based HPV vaccination in the personal sector could not enhance HPV vaccination protection to an optimum degree. Since misinformation was the primary driver of unfavourable attitudes ensuing in <20% of ladies being vaccinated, an advocacy marketing campaign concentrating on all stakeholders is urgently wanted.
Persistent Human Papillomavirus Infection
Persistent an infection with oncogenic human papillomavirus (HPV) sorts is answerable for ~5% of human cancers. The HPV infectious cycle can maintain long-term an infection in stratified epithelia as a result of viral DNA is maintained as low copy quantity extrachromosomal plasmids in the dividing basal cells of a lesion, whereas progeny viral genomes are amplified to giant numbers in differentiated superficial cells. The viral E1 and E2 proteins provoke viral DNA replication and preserve and partition viral genomes, in live performance with the mobile replication equipment. Additionally, the E5, E6, and E7 proteins are required to evade host immune responses and to provide a mobile surroundings that helps viral DNA replication. An unlucky consequence of the manipulation of mobile proliferation and differentiation is that cells develop into at excessive threat for carcinogenesis.
The Human Papillomavirus (HPV) is the causative agent of various sorts of tumors, together with cervical cancers, non-melanoma pores and skin cancers, anogenital cancers, and head and neck cancers. Despite the vaccination campaigns applied over the past many years, we’re removed from eradicating HPV-driven malignancies. Moreover, the dearth of focused therapies to sort out HPV-related tumors exacerbates this downside. Biomarkers for early detection of the pathology and extra tailor-made therapeutic approaches are wanted, and an entire understanding of HPV-driven tumorigenesis is crucial to achieve this objective. In this evaluate, we overview the molecular pathways implicated in HPV an infection and carcinogenesis, emphasizing the potential targets for brand spanking new therapeutic methods in addition to new biomarkers.

De-Escalated Adjuvant Therapy after Transoral Robotic Surgery for Human Papillomavirus-Related Oropharyngeal Carcinoma: The Sinai Robotic Surgery (SIRS) Trial
Treatment of human papillomavirus-related oropharyngeal squamous cell carcinoma (HPVOPC) outcomes in unprecedented excessive survival charges however probably pointless toxicity. We hypothesized that upfront surgical procedure and neck dissection adopted by reduced-dose adjuvant remedy for early and intermediate HPVOPC would finally consequence in equal progression-free survival (PFS) and total survival whereas decreasing toxicity. This research is a nonrandomized part II trial for early-stage HPVOPC handled with transoral robotic surgical procedure (TORS) adopted by reduced-dose radiotherapy.
Patients with beforehand untreated p16-positive HPVOPC and < 20 pack years’ smoking historical past have been enrolled. After robotic surgical procedure, sufferers have been assigned to group 1 (no poor threat options; surveillance), group 2 (intermediate pathologic threat components [perineural invasion, lymphovascular invasion]; 50-Gy radiotherapy), or group 3 (poor prognostic pathologic components [ECE, more than three positive lymph nodes and positive margin]; concurrent 56-Gy chemoradiotherapy with weekly cisplatin).
Fifty-four sufferers have been evaluable; there have been 25 in group 1, 15 in group 2, and 14 in group 3. Median follow-up was 43.9 months (9.6-75.8). Disease-specific survival was 98.1%, and PFS was 90.7%. PFS likelihood by way of Kaplan-Meier was 91.3% for group 1, 86.7% for group 2, and 93.3% for group 3. There have been 4 locoregional failures (LRFs), together with one distant metastasis and one contralateral second major. Average time to LRF was 46.Three months (9.6-59.0); 4 LRFs have been efficiently salvaged, and the sufferers stay illness free (11.0-42.7 months); one topic stays alive with illness.
Human papillomavirus IgG(HPV-IgG)ELISA Kit |
GA-E1119HM-48T |
GenAsia Biotech |
48T |
EUR 289 |
Human papillomavirus IgG(HPV-IgG)ELISA Kit |
GA-E1119HM-96T |
GenAsia Biotech |
96T |
EUR 466 |
human papillomavirus IgG,HPV-IgG ELISA Kit |
201-12-1103 |
SunredBio |
96 tests |
EUR 440 |
|
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids. |
Human Papillomavirus IgG (HPV IgG) ELISA Kit |
abx052750-96tests |
Abbexa |
96 tests |
EUR 668 |
|
ELISA kit for Human papillomavirus antibody (IgG) |
EK0266 |
SAB |
96 tests |
EUR 712 |
Description: Enzyme-linked immunosorbent assay kit for quantification of Human papillomavirus antibody (IgG) in samples from serum, plasma, tissue homogenates and other biological fluids. |
Human papillomavirus type 18 L1-capsids(HPV18L1) antibody (IgG) ELISA kit |
CSB-EQ027476HU-24T |
Cusabio |
1 plate of 24 wells |
EUR 165 |
|
Description: Qualitative indirect ELISA kit for measuring Human papillomavirus type 18 L1-capsids (HPV18L1) antibody (IgG) in samples from serum, plasma. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price. |
Human papillomavirus type 18 L1-capsids(HPV18L1) antibody (IgG) ELISA kit |
1-CSB-EQ027476HU |
Cusabio |
-
EUR 602.00
-
EUR 4238.00
-
EUR 2256.00
|
- 1 plate of 96 wells
- 10 plates of 96 wells each
- 5 plates of 96 wells each
|
|
Description: Qualitative indirect ELISA kit for measuring Human papillomavirus type 18 L1-capsids(HPV18L1) antibody (IgG) in samples from serum, plasma. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits. |
Human papillomavirus type 16 L1-capsids(HPV16L1) antibody (IgG) ELISA kit |
CSB-EQ027477HU-24T |
Cusabio |
1 plate of 24 wells |
EUR 165 |
|
Description: Qualitative indirect ELISA kit for measuring Human papillomavirus type 16 L1-capsids (HPV16L1) antibody (IgG) in samples from serum, plasma. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price. |
Human papillomavirus type 16 L1-capsids(HPV16L1) antibody (IgG) ELISA kit |
1-CSB-EQ027477HU |
Cusabio |
-
EUR 602.00
-
EUR 4238.00
-
EUR 2256.00
|
- 1 plate of 96 wells
- 10 plates of 96 wells each
- 5 plates of 96 wells each
|
|
Description: Qualitative indirect ELISA kit for measuring Human papillomavirus type 16 L1-capsids(HPV16L1) antibody (IgG) in samples from serum, plasma. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits. |
Rabbit papillomavirus type 16 L1-capsids antibody(IgG)ELISA Kit |
CSB-E14279Rb-24T |
Cusabio |
1 plate of 24 wells |
EUR 165 |
|
Description: Quantitativesandwich ELISA kit for measuring Rabbit papillomavirus type 16 L1-capsids antibody (IgG) in samples from serum, plasma, cell culture supernates, tissue homogenates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price. |
Rabbit papillomavirus type 16 L1-capsids antibody(IgG)ELISA Kit |
1-CSB-E14279Rb |
Cusabio |
-
EUR 900.00
-
EUR 5476.00
-
EUR 2900.00
|
- 1 plate of 96 wells
- 10 plates of 96 wells each
- 5 plates of 96 wells each
|
|
Description: Quantitativesandwich ELISA kit for measuring Rabbit papillomavirus type 16 L1-capsids antibody(IgG) in samples from serum, plasma, cell culture supernates, tissue homogenates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits. |
Rabbit papillomavirus type 18 L1-capsids antibody(IgG)ELISA Kit |
CSB-E14280Rb-24T |
Cusabio |
1 plate of 24 wells |
EUR 165 |
|
Description: Quantitativesandwich ELISA kit for measuring Rabbit papillomavirus type 18 L1-capsids antibody (IgG) in samples from serum, plasma, cell culture supernates, tissue homogenates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price. |
Rabbit papillomavirus type 18 L1-capsids antibody(IgG)ELISA Kit |
1-CSB-E14280Rb |
Cusabio |
-
EUR 900.00
-
EUR 5476.00
-
EUR 2900.00
|
- 1 plate of 96 wells
- 10 plates of 96 wells each
- 5 plates of 96 wells each
|
|
Description: Quantitativesandwich ELISA kit for measuring Rabbit papillomavirus type 18 L1-capsids antibody(IgG) in samples from serum, plasma, cell culture supernates, tissue homogenates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits. |
Anti-Papillomavirus type 1E2-protein Antibody |
STJ60003 |
St John's Laboratory |
100 µg |
EUR 424 |
Description: May be part of the rubber biosynthesis machinery. Plays a role in rubber elongation, Latex allergen |
Anti-Papillomavirus type 1E2-protein Antibody |
STJ60004 |
St John's Laboratory |
100 µg |
EUR 424 |
Description: N-acetyl-D-glucosamine / N-acetyl-D-neuraminic acid binding lectin. Can inhibit fungal growth |
Anti-Papillomavirus type 1E2-protein Antibody |
STJ60005 |
St John's Laboratory |
100 µg |
EUR 424 |
Description: N-acetyl-D-glucosamine / N-acetyl-D-neuraminic acid binding lectin. Can inhibit fungal growth |
Anti-Papillomavirus type 1E2-protein Antibody |
STJ60006 |
St John's Laboratory |
100 µg |
EUR 424 |
Description: Involved in the biosynthesis of rubber, an isoprenoid polymer (cis-1,4-polyisoprene), latex allergen |
Anti-Papillomavirus type 1E2-protein Antibody |
STJ60007 |
St John's Laboratory |
100 µg |
EUR 424 |
Description: May be part of the rubber biosynthesis machinery. Plays a role in rubber elongation, Latex allergen |
Anti-Papillomavirus type 1E2-protein Antibody |
STJ60008 |
St John's Laboratory |
100 µg |
EUR 424 |
Description: Involved in the biosynthesis of rubber, an isoprenoid polymer (cis-1,4-polyisoprene), latex allergen |
Anti-Papillomavirus type 1E2-protein Antibody |
STJ60009 |
St John's Laboratory |
100 µg |
EUR 424 |
Description: Causes an allergic reaction in human. Major latex allergen, a major cause of anaphylaxis in susceptible individuals, especially health care workers. 92% of health care workers with latex allergy have IgE specific to the Hev b 5 protein |
Anti-Papillomavirus type 1E2-protein Antibody |
STJ60010 |
St John's Laboratory |
100 µg |
EUR 424 |
Description: Causes an allergic reaction in human. Major latex allergen, a major cause of anaphylaxis in susceptible individuals, especially health care workers. 92% of health care workers with latex allergy have IgE specific to the Hev b 5 protein |
ELISA kit for Human papillomavirus type 16 L1-capsids (HPV16L1) antibody (IgG) |
EK0269 |
SAB |
96 tests |
EUR 712 |
Description: Enzyme-linked immunosorbent assay kit for quantification of Human papillomavirus type 16 L1-capsids (HPV16L1) antibody (IgG) in samples from serum, plasma, tissue homogenates and other biological fluids. |
ELISA kit for Human papillomavirus type 18 L1-capsids (HPV18L1) antibody (IgG) |
EK0271 |
SAB |
96 tests |
EUR 712 |
Description: Enzyme-linked immunosorbent assay kit for quantification of Human papillomavirus type 18 L1-capsids (HPV18L1) antibody (IgG) in samples from serum, plasma, tissue homogenates and other biological fluids. |
ELISA kit for Rabbit Papillomavirus type 18 L1-capsids IgG antibody |
KTE90138-48T |
Abbkine |
48T |
EUR 354 |
|
Description: Quantitative sandwich ELISA for measuring Rabbit Papillomavirus type 18 L1-capsids IgG antibody in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
ELISA kit for Rabbit Papillomavirus type 18 L1-capsids IgG antibody |
KTE90138-5platesof96wells |
Abbkine |
5 plates of 96 wells |
EUR 2252 |
|
Description: Quantitative sandwich ELISA for measuring Rabbit Papillomavirus type 18 L1-capsids IgG antibody in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
ELISA kit for Rabbit Papillomavirus type 18 L1-capsids IgG antibody |
KTE90138-96T |
Abbkine |
96T |
EUR 572 |
|
Description: Quantitative sandwich ELISA for measuring Rabbit Papillomavirus type 18 L1-capsids IgG antibody in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
ELISA kit for Rabbit Papillomavirus type 16 L1-capsids IgG antibody |
KTE90139-48T |
Abbkine |
48T |
EUR 354 |
|
Description: Quantitative sandwich ELISA for measuring Rabbit Papillomavirus type 16 L1-capsids IgG antibody in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
ELISA kit for Rabbit Papillomavirus type 16 L1-capsids IgG antibody |
KTE90139-5platesof96wells |
Abbkine |
5 plates of 96 wells |
EUR 2252 |
|
Description: Quantitative sandwich ELISA for measuring Rabbit Papillomavirus type 16 L1-capsids IgG antibody in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
ELISA kit for Rabbit Papillomavirus type 16 L1-capsids IgG antibody |
KTE90139-96T |
Abbkine |
96T |
EUR 572 |
|
Description: Quantitative sandwich ELISA for measuring Rabbit Papillomavirus type 16 L1-capsids IgG antibody in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
17-Hydroxyprogesterone (17-OHP) ELISA Kit |
DLR-17-OHP-Ge-48T |
DL Develop |
48T |
EUR 469 |
|
Description: A competitive inhibition quantitative ELISA assay kit for detection of 17-Hydroxyprogesterone (17-OHP) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
17-Hydroxyprogesterone (17-OHP) ELISA Kit |
DLR-17-OHP-Ge-96T |
DL Develop |
96T |
EUR 608 |
|
Description: A competitive inhibition quantitative ELISA assay kit for detection of 17-Hydroxyprogesterone (17-OHP) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Human Papillomavirus Type 18 ?HPV18?ELISA Kit |
201-12-2024 |
SunredBio |
96 tests |
EUR 440 |
|
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids. |
Papillomavirus L1-Capsids Antibody (IgG) (Human ) ELISA Kit (OKCA00473) |
OKCA00473 |
Aviva Systems Biology |
96 Wells |
EUR 859 |
Description: Description of target: Papillomavirus L1-Capsids Antibody (IgG);Species reactivity: Human ;Application: ;Assay info: Assay Methodology: Qualitative Reverse Capture ELISA;Sensitivity: |
General 17-Hydroxyprogesterone (17-OHP) ELISA Kit |
RD-17-OHP-Ge-96Tests |
Reddot Biotech |
96 Tests |
EUR 646 |
General 17-Hydroxyprogesterone (17-OHP) ELISA Kit |
RDR-17-OHP-Ge-48Tests |
Reddot Biotech |
48 Tests |
EUR 488 |
General 17-Hydroxyprogesterone (17-OHP) ELISA Kit |
RDR-17-OHP-Ge-96Tests |
Reddot Biotech |
96 Tests |
EUR 676 |
General 17-Hydroxyprogesterone (17-OHP) ELISA Kit |
RD-17-OHP-Ge-48Tests |
Cusabio |
48 Tests |
EUR 467 |
Human papillomavirus type 16(HPV16) antibody (IgM) ELISA kit |
CSB-EQ027772HU-24T |
Cusabio |
1 plate of 24 wells |
EUR 165 |
|
Description: Quantitative sandwich ELISA kit for measuring Human papillomavirus type 16 (HPV16) antibody (IgM) in samples from serum, plasma. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price. |
Human papillomavirus type 16(HPV16) antibody (IgM) ELISA kit |
1-CSB-EQ027772HU |
Cusabio |
-
EUR 602.00
-
EUR 4238.00
-
EUR 2256.00
|
- 1 plate of 96 wells
- 10 plates of 96 wells each
- 5 plates of 96 wells each
|
|
Description: Quantitative sandwich ELISA kit for measuring Human papillomavirus type 16(HPV16) antibody (IgM) in samples from serum, plasma. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits. |
Human papillomavirus type 18 (HPV18) antibody (IgM) ELISA kit |
CSB-EQ028067HU-24T |
Cusabio |
1 plate of 24 wells |
EUR 165 |
|
Description: Quantitativesandwich ELISA kit for measuring Human papillomavirus type 18 (HPV18) antibody (IgM) in samples from serum, plasma. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price. |
Human papillomavirus type 18 (HPV18) antibody (IgM) ELISA kit |
1-CSB-EQ028067HU |
Cusabio |
-
EUR 804.00
-
EUR 5099.00
-
EUR 2704.00
|
- 1 plate of 96 wells
- 10 plates of 96 wells each
- 5 plates of 96 wells each
|
|
Description: Quantitativesandwich ELISA kit for measuring Human papillomavirus type 18 (HPV18) antibody (IgM) in samples from serum, plasma. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits. |
Human Immunoglobulin G (IgG) ELISA Kit |
DLR-IgG-Hu-48T |
DL Develop |
48T |
EUR 239 |
|
Description: A competitive inhibition quantitative ELISA assay kit for detection of Human Immunoglobulin G (IgG) in samples from serum, plasma or other biological fluids. |
Human Immunoglobulin G (IgG) ELISA Kit |
DLR-IgG-Hu-96T |
DL Develop |
96T |
EUR 292 |
|
Description: A competitive inhibition quantitative ELISA assay kit for detection of Human Immunoglobulin G (IgG) in samples from serum, plasma or other biological fluids. |
Human Immunoglobulin G (IgG) ELISA Kit |
RDR-IgG-Hu-48Tests |
Reddot Biotech |
48 Tests |
EUR 216 |
Human Immunoglobulin G (IgG) ELISA Kit |
RDR-IgG-Hu-96Tests |
Reddot Biotech |
96 Tests |
EUR 287 |
Human Papillomavirus Type 18 L1 ?HPV18L1?ELISA Kit |
201-12-2025 |
SunredBio |
96 tests |
EUR 440 |
|
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids. |
Human Papillomavirus Type 18 (HPV 18) ELISA Kit |
abx052654-96tests |
Abbexa |
96 tests |
EUR 668 |
|
Rabbit Polyclonal antibody Anti-CRBN |
Anti-CRBN |
ImmunoStep |
50 µg |
EUR 349 |
ELISA kit for Human papillomavirus type 16 (HPV16) antibody (IgM) |
EK0270 |
SAB |
96 tests |
EUR 712 |
Description: Enzyme-linked immunosorbent assay kit for quantification of Human papillomavirus type 16 (HPV16) antibody (IgM) in samples from serum, plasma, tissue homogenates and other biological fluids. |
Papillomavirus type 16 Protein E6 Antibody |
20-abx110070 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Papillomavirus type 18 Protein E7 Antibody |
20-abx110071 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Human papillomavirus antibody(IgM) ELISA Kit |
CSB-E08783h-24T |
Cusabio |
1 plate of 24 wells |
EUR 165 |
|
Description: Quantitative sandwich ELISA kit for measuring Human papillomavirus antibody (IgM) in samples from serum, plasma, cell culture supernates, tissue homogenates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price. |
Human papillomavirus antibody(IgM) ELISA Kit |
1-CSB-E08783h |
Cusabio |
-
EUR 602.00
-
EUR 4238.00
-
EUR 2256.00
|
- 1 plate of 96 wells
- 10 plates of 96 wells each
- 5 plates of 96 wells each
|
|
Description: Quantitative sandwich ELISA kit for measuring Human papillomavirus antibody(IgM) in samples from serum, plasma, cell culture supernates, tissue homogenates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits. |
Bovine Immunoglobulin G (IgG) ELISA Kit |
DLR-IgG-b-48T |
DL Develop |
48T |
EUR 456 |
|
Description: A competitive inhibition quantitative ELISA assay kit for detection of Bovine Immunoglobulin G (IgG) in samples from serum, plasma or other biological fluids. |
Bovine Immunoglobulin G (IgG) ELISA Kit |
DLR-IgG-b-96T |
DL Develop |
96T |
EUR 590 |
|
Description: A competitive inhibition quantitative ELISA assay kit for detection of Bovine Immunoglobulin G (IgG) in samples from serum, plasma or other biological fluids. |
Canine Immunoglobulin G (IgG) ELISA Kit |
DLR-IgG-c-48T |
DL Develop |
48T |
EUR 441 |
|
Description: A competitive inhibition quantitative ELISA assay kit for detection of Canine Immunoglobulin G (IgG) in samples from serum, plasma or other biological fluids. |
Canine Immunoglobulin G (IgG) ELISA Kit |
DLR-IgG-c-96T |
DL Develop |
96T |
EUR 570 |
|
Description: A competitive inhibition quantitative ELISA assay kit for detection of Canine Immunoglobulin G (IgG) in samples from serum, plasma or other biological fluids. |
Equine Immunoglobulin G (IgG) ELISA Kit |
DLR-IgG-Eq-48T |
DL Develop |
48T |
EUR 360 |
|
Description: A competitive inhibition quantitative ELISA assay kit for detection of Equine Immunoglobulin G (IgG) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Equine Immunoglobulin G (IgG) ELISA Kit |
DLR-IgG-Eq-96T |
DL Develop |
96T |
EUR 457 |
|
Description: A competitive inhibition quantitative ELISA assay kit for detection of Equine Immunoglobulin G (IgG) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Goat Immunoglobulin G (IgG) ELISA Kit |
DLR-IgG-g-48T |
DL Develop |
48T |
EUR 464 |
|
Description: A competitive inhibition quantitative ELISA assay kit for detection of Goat Immunoglobulin G (IgG) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Goat Immunoglobulin G (IgG) ELISA Kit |
DLR-IgG-g-96T |
DL Develop |
96T |
EUR 601 |
|
Description: A competitive inhibition quantitative ELISA assay kit for detection of Goat Immunoglobulin G (IgG) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Mouse Immunoglobulin G (IgG) ELISA Kit |
DLR-IgG-Mu-48T |
DL Develop |
48T |
EUR 328 |
|
Description: A competitive inhibition quantitative ELISA assay kit for detection of Mouse Immunoglobulin G (IgG) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Mouse Immunoglobulin G (IgG) ELISA Kit |
DLR-IgG-Mu-96T |
DL Develop |
96T |
EUR 415 |
|
Description: A competitive inhibition quantitative ELISA assay kit for detection of Mouse Immunoglobulin G (IgG) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Porcine Immunoglobulin G (IgG) ELISA Kit |
DLR-IgG-p-48T |
DL Develop |
48T |
EUR 456 |
|
Description: A competitive inhibition quantitative ELISA assay kit for detection of Porcine Immunoglobulin G (IgG) in samples from serum, plasma, tissue homogenates or other biological fluids. |
Porcine Immunoglobulin G (IgG) ELISA Kit |
DLR-IgG-p-96T |
DL Develop |
96T |
EUR 590 |
|
Description: A competitive inhibition quantitative ELISA assay kit for detection of Porcine Immunoglobulin G (IgG) in samples from serum, plasma, tissue homogenates or other biological fluids. |
Rat Immunoglobulin G (IgG) ELISA Kit |
DLR-IgG-Ra-48T |
DL Develop |
48T |
EUR 334 |
|
Description: A competitive inhibition quantitative ELISA assay kit for detection of Rat Immunoglobulin G (IgG) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Rat Immunoglobulin G (IgG) ELISA Kit |
DLR-IgG-Ra-96T |
DL Develop |
96T |
EUR 422 |
|
Description: A competitive inhibition quantitative ELISA assay kit for detection of Rat Immunoglobulin G (IgG) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Rabbit Immunoglobulin G (IgG) ELISA Kit |
DLR-IgG-Rb-48T |
DL Develop |
48T |
EUR 337 |
|
Description: A competitive inhibition quantitative ELISA assay kit for detection of Rabbit Immunoglobulin G (IgG) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Rabbit Immunoglobulin G (IgG) ELISA Kit |
DLR-IgG-Rb-96T |
DL Develop |
96T |
EUR 426 |
|
Description: A competitive inhibition quantitative ELISA assay kit for detection of Rabbit Immunoglobulin G (IgG) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Bovine Immunoglobulin G (IgG) ELISA Kit |
RDR-IgG-b-48Tests |
Reddot Biotech |
48 Tests |
EUR 473 |
Bovine Immunoglobulin G (IgG) ELISA Kit |
RDR-IgG-b-96Tests |
Reddot Biotech |
96 Tests |
EUR 654 |
Canine Immunoglobulin G (IgG) ELISA Kit |
RDR-IgG-c-48Tests |
Reddot Biotech |
48 Tests |
EUR 455 |
Canine Immunoglobulin G (IgG) ELISA Kit |
RDR-IgG-c-96Tests |
Reddot Biotech |
96 Tests |
EUR 629 |
Equine Immunoglobulin G (IgG) ELISA Kit |
RDR-IgG-Eq-48Tests |
Reddot Biotech |
48 Tests |
EUR 358 |
Equine Immunoglobulin G (IgG) ELISA Kit |
RDR-IgG-Eq-96Tests |
Reddot Biotech |
96 Tests |
EUR 490 |
Goat Immunoglobulin G (IgG) ELISA Kit |
RDR-IgG-g-48Tests |
Reddot Biotech |
48 Tests |
EUR 482 |
Goat Immunoglobulin G (IgG) ELISA Kit |
RDR-IgG-g-96Tests |
Reddot Biotech |
96 Tests |
EUR 667 |
Mouse Immunoglobulin G (IgG) ELISA Kit |
RDR-IgG-Mu-48Tests |
Reddot Biotech |
48 Tests |
EUR 321 |
Mouse Immunoglobulin G (IgG) ELISA Kit |
RDR-IgG-Mu-96Tests |
Reddot Biotech |
96 Tests |
EUR 438 |
Porcine Immunoglobulin G (IgG) ELISA Kit |
RDR-IgG-p-48Tests |
Reddot Biotech |
48 Tests |
EUR 473 |
Porcine Immunoglobulin G (IgG) ELISA Kit |
RDR-IgG-p-96Tests |
Reddot Biotech |
96 Tests |
EUR 654 |
Rat Immunoglobulin G (IgG) ELISA Kit |
RDR-IgG-Ra-48Tests |
Reddot Biotech |
48 Tests |
EUR 328 |
Rat Immunoglobulin G (IgG) ELISA Kit |
RDR-IgG-Ra-96Tests |
Reddot Biotech |
96 Tests |
EUR 447 |
Rabbit Immunoglobulin G (IgG) ELISA Kit |
RDR-IgG-Rb-48Tests |
Reddot Biotech |
48 Tests |
EUR 331 |
Rabbit Immunoglobulin G (IgG) ELISA Kit |
RDR-IgG-Rb-96Tests |
Reddot Biotech |
96 Tests |
EUR 451 |
Bovine Immunoglobulin G (IgG) ELISA Kit |
RD-IgG-b-48Tests |
Reddot Biotech |
48 Tests |
EUR 453 |
Bovine Immunoglobulin G (IgG) ELISA Kit |
RD-IgG-b-96Tests |
Reddot Biotech |
96 Tests |
EUR 625 |
Porcine Immunoglobulin G (IgG) ELISA Kit |
RD-IgG-p-48Tests |
Reddot Biotech |
48 Tests |
EUR 453 |
Porcine Immunoglobulin G (IgG) ELISA Kit |
RD-IgG-p-96Tests |
Reddot Biotech |
96 Tests |
EUR 625 |
Rat Immunoglobulin G (IgG) ELISA Kit |
RD-IgG-Ra-48Tests |
Reddot Biotech |
48 Tests |
EUR 314 |
The outcomes point out that upfront surgical procedure with neck dissection with reduced-dose radiation for T1-2, N1 stage (by the eighth version American Joint Committee on Cancer staging guide) HPVOPC outcomes in favorable survival with glorious operate in this inhabitants. These outcomes assist radiation dose discount after TORS as a de-escalation technique in HPVOPC.